Darbinurad
   HOME

TheInfoList



OR:

Darbinurad is a
investigational new drug The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical industry, pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug inte ...
that is being evaluated for the treatment of
gout Gout ( ) is a form of inflammatory arthritis characterized by recurrent attacks of pain in a red, tender, hot, and Joint effusion, swollen joint, caused by the deposition of needle-like crystals of uric acid known as monosodium urate crysta ...
. It is a selective urate transporter 1 (URAT1) inhibitor that blocks the reabsorption of
uric acid Uric acid is a heterocyclic compound of carbon, nitrogen, oxygen, and hydrogen with the Chemical formula, formula C5H4N4O3. It forms ions and salts known as urates and acid urates, such as ammonium acid urate. Uric acid is a product of the meta ...
within the renal
proximal tubule The proximal tubule is the segment of the nephron in kidneys which begins from the renal (tubular) pole of the Bowman's capsule to the beginning of loop of Henle. At this location, the glomerular parietal epithelial cells (PECs) lining bowman’s ...
, thereby reducing serum uric acid concentrations.


References

Antigout agents Benzonitriles Carboxylic acids Cyclopropanes Disubstituted pyridines Thioethers {{musculoskeletal-drug-stub